Clomiphene citrate in the twenty-first century

Human Fertility

Volumn 4, Issue 3, 2001, Pages 145-151

  Nasseri, S ^a   Ledger, W L ^a  

^a JESSOP HOSPITAL FOR WOMEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIFENE CITRATE; ESTROGEN; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; METFORMIN; NALTREXONE; PREDNISONE; ZUCLOMIFENE;

AMENORRHEA; ANOVULATION; CANCER RISK; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; DIATHERMY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG ABSORPTION; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG COST; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDICATION; DRUG MONITORING; FERTILIZATION IN VITRO; FETUS RISK; GASTROINTESTINAL SYMPTOM; HIGH RISK PREGNANCY; HOT FLUSH; HUMAN; HYPERANDROGENISM; INFERTILITY; INSULIN RESISTANCE; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; MENSTRUAL CYCLE; MULTIPLE PREGNANCY; OBESITY; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY RATE; PRESCRIPTION; REVIEW; RISK FACTOR; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0034882093     PISSN: 14647273     EISSN: None     Source Type: Journal    
DOI: 10.1080/1464727012000199212     Document Type: Review

References (68)

1. Clomiphene citrate: Mechanism(s) and site(s) of action - A hypothesis revisited
2. Clomiphene citrate-initiated ovulation
3. Ovulation initiation: Clomiphene citrate
4. Laparoscopic ovarian diathermy: An effective treatment for antioestrogen resistant anovulatory infertility in women with polycystic ovary syndrome
5. Frequency of infertility and induction of ovulation in Iranian ovarian cancer patients. Abstract from the 15th Annual Meeting of ESHRE
6. Hypersecretion of LH: A significant cause of infertility and miscarriage
7. Analysis of clomiphene isomers in human plasma and detection of metabolites using reversed-phase chromatography and fluorescence detection
8. Infertility
9. Agonistic and antagonistic effects of clomiphene citrate and its isomers
10. The agonist-antagonist properties of clomiphene
11. Pharmacological interventions for the induction of ovulation
12. Current clinical use of anti-oestrogen
13. Adjunctive medical treatment in follicular stimulation
14. Development, pharmacology and clinical experience with clomiphene citrate
15. Incidence of spontaneous abortion in clomiphene pregnancies
16. A role of clomiphene in the 21st century?
17. Surgically induced ovulation in the polycystic ovary syndrome: Wedge resection revisited in the age of laparoscopy
18. The effect of clomiphene citrate on follicular phase increase in endometrial thickness and uterine volume
19. Anovulatory infertility
20. Laparoscopic treatment of polycystic ovaries with insulated needle cautery: A reappraisal
21. Follicular stimulation for high-tech pregnancies; are we playing it safe?
22. Follicle-stimulating hormone - Inhibin B interactions during the follicular phase of the primate menstrual cycle revealed by gonadotropin-releasing hormone antagonist and antiestrogen treatment
23. Ovarian electrocautery versus human menopausal gonadotrophins and pure follicle stimulating hormone therapy in the treatment of patients with polycystic ovarian disease
24. The effect of clomiphene citrate and menopausal gonadotrophins on cervical mucous in ovulatory cycles
25. A decade's experience with an individualised clomiphene treatment regimen including its effect on the postcoital test
26. Monitoring techniques for improved pregnancy rates during clomiphene ovulation induction
27. Factors affecting the pregnancy rate in clomiphene citrate induction of ovulation
28. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligo/amenorrheic infertility
29. Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligo/amenorrheic infertility
30. Extended clomiphene citrate and prednisone for treatment of chronic anovulation resistant to clomiphene citrate alone
31. Ovulation induction
32. Hypothalamic-pituitary-ovarian response to clomiphene citrate in women with polycystic ovarian syndrome
33. Modern use of clomiphene citrate in induction of ovulation
34. Higher multiple births and the modern management of infertility in Britain
35. A prospective, randomised, crossover study comparing the effects of clomiphene citrate and cyclofenil on endometrial morphology in the luteal phase of normal, fertile women
36. Factors affecting the outcome of laparoscopic ovarian drilling for polycystic ovarian syndrome in women with anovulatory infertility
37. Clinical and laboratory predictors of clomiphene response
38. Anti-oestrogens
39. Clomiphene citrate affects cervical mucous and endometrial morphology independently of the changes in plasma hormonal levels induced by multiple follicular recruitment
40. Single dose pharmacokinetics of clomiphene citrate in normal volunteers
41. Risk of neural tube defects in relation to maternal fertility and fertility drug use
42. Cancer incidence in a cohort of infertile women
43. Fecundity and infertility in the United States: Incidence and trends
44. Polycystic ovary syndrome, insulin resistance and ovulatory responses to clomiphene citrate
45. Decreases in ovarian cytochrome P450 17alfa activity and serum free testosterone after reduction in insulin secretion in polycystic ovary syndrome
46. Effects of metformin on spontaneous and clomiphene induced ovulation in the polycystic ovary syndrome
47. Weight control and its beneficial effect on fertility in women with obesity and polycystic ovary syndrome
48. Further clinical experience with clomiphene citrate in women with polycystic ovary syndrome: The difference between responders and non-responders
49. Fertility drugs and the risk of breast and ovarian cancers: Results of a long-term follow-up study
50. Clomiphene citrate
51. Successful induction of ovulation in normogonadotrophic clomiphene resistant anovulatory women by combined naltrexone and clomiphene citrate treatment
52. Growth hormone response to clonidine in anovulatory infertile women resistant to clomiphene citrate stimulation
53. Ovarian tumors in a cohort of infertile women
54. Risk of breast cancer in a cohort of infertile women
55. Disorders of ovulation
56. Hormonal profiles following clomiphene citrate therapy in conception and non-conception cycles
57. Early miscarriage and fetal malformations after induction of ovulation (by clomiphene citrate and/or human menotropins), in vitro fertilization and gamete intrafallopian transfer
58. Induction of ovulation
59. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus
60. Management of male infertility
61. The effects of clomiphene citrate and cyclofenil on cervical mucus volume and receptivity over the periovulatory period
62. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone
63. Risk of breast cancer after use of fertility drugs with in vitro fertilization
64. Short- and long-term effects of ovulation induction
65. Treatment of male infertility
66. Characteristics related to ovarian cancer risk: Collaborative analysis of twelve US case-control studies. II: Invasive epithelial cancers in white women
67. Use of fertility drugs in United States, 1973 through 1991